Search the Newsreel

Wrap Technologies prices $12M stock offering at $1.40 per share

Wrap Technologies Inc. announced the pricing of a registered direct offering of 8,571,609 shares of common stock or pre-funded warrants at $1.40 per share, aiming to raise approximately $12.0 million. The public safety technology company intends to use the proceeds for general corporate purposes …

Oppenheimer Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $82

Oppenheimer has reiterated its Buy rating on Quince Therapeutics (QNCX.US), maintaining a target price of $82. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

OCUL Stock Climbs As FDA Clears Path For AXPAXLI NDA

Ocular Therapeutix Inc. (OCUL) stock climbed by 8.12% after the FDA agreed that a single successful Phase 3 SOL-1 trial, combined with safety data, is sufficient for an AXPAXLI wet AMD New Drug Application (NDA) via the 505(b)(2) pathway. The company reported a Q2 …

West Coast Paper Mills passes all 8 resolutions at 71st AGM

At US$507, Is Applied Materials, Inc. (NASDAQ:AMAT) Worth Looking At Closely?

This article analyzes Applied Materials, Inc. (NASDAQ:AMAT) from a valuation perspective, questioning if its current share price of US$507 makes it an attractive investment. It suggests a closer look at the company's financial health and future prospects to determine if it is undervalued or …

Apple’s $54 billion iPhone machine may be about to break its biggest ritual

For nearly two decades, September has usually meant one thing for Apple investors: a new iPhone cycle. That pattern may be about to change. Apple (AAPL) is reportedly planning to launch the iPhone 18 Pro series this fall and delay the standard iPhone 18 …

OCUL Stock Climbs As FDA Path And Cash Runway De‑Risk Story

Applied Materials Inc. stock outperforms competitors on strong trading day

Shares of Applied Materials Inc. (AMAT) rose 5.55% to $535.31 on Monday, outperforming the broader market which saw declines in the S&P 500 Index and Dow Jones Industrial Average. This increase snapped a two-day losing streak for the stock.

Snap Drops 3% After Ninth Circuit Strips Away Its Immunity Shield, Reddit Eases

Quick Read The 9th Circuit stripped Snap's Section 230 immunity, opening 3,000+ lawsuits and sending SNAP shares down 3% after an overnight plunge to $4.74. Meta and Pinterest fell 3% and 4%, respectively, as the ruling cast an industry-wide liability shadow across social media …

HCLTech Pairs NetApp Keystone With U4X to Sell Enterprise AI Storage by Consumption

HCLTech and NetApp have expanded their partnership to offer a hybrid cloud Storage-as-a-Service (STaaS) platform designed for enterprise AI, generative AI, and high-performance data needs. This new offering integrates HCLTech's U4X framework with NetApp Keystone, providing a pay-as-you-go model that aligns infrastructure consumption with …

Capri Holdings stock hits 52-week low at 14.77 USD By Investing.com

Capri Holdings Ltd (CPRI) stock has fallen to a 52-week low of $14.77, representing a 37% year-to-date decline. Despite this, the company recently exceeded profit expectations in its fiscal first quarter, reporting adjusted earnings of $0.67 per share and revenue of $769 million, driven …

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Tenax Therapeutics (TENX)

Levi & Korsinsky, LLP is investigating potential securities law violations involving Tenax Therapeutics (TENX) after its shares dropped 84-85%. This significant decline followed the disclosure that the Phase 3 LEVEL trial of its lead drug, TNX-103, failed to meet both its primary and key …

Ocular Therapeutix (NASDAQ:OCUL) Shares Gap Up - Should You Buy?

Fulcrum Therapeutics shuts down, reverse-merges with N.C. biotech Slate

Fulcrum Therapeutics, which previously cut 85% of its workforce after discontinuing its sickle cell disease program, is undergoing a reverse merger with North Carolina-based Slate Medicines. The merger is anticipated to finalize in the fourth quarter of the year. Fulcrum is currently located at …

Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies

By Karen Roman Fulcrum Therapeutics, Inc. (Nasdaq: FULC) said it is merging with Slate Medicines, Inc. to advance next-generation therapeutics to treat migraine and other headache disorders, with the combining company operating as Slate Medicines, Inc. and trading on Nasdaq under the ticker "SLTE." …

Marcus & Millichap Announces Sale of Staybridge Suites Las Cruces

Marcus & Millichap has announced the sale of a 115-room Staybridge Suites hotel in Las Cruces, New Mexico. The transaction was facilitated by investment specialists Skyler Cooper and Chris Gomes, and New Mexico broker of record Ryan Sarbinoff, who represented the seller and procured …

Apple upgraded at Rothschild to Buy on product strength (AAPL:NASDAQ)

Rothschild has upgraded Apple (AAPL) to Buy from Hold, citing the company's strong product lineup and potential entry into the foldable handset market. Despite the firm acknowledging that "Apple Intelligence has been disappointing," the overall outlook on Apple's product strength led to the upgrade. …

Why Did QuantumScape Stock Sink Over 10% After-Hours Today?

Apple’s Fitness+ service may be getting a live upgrade

Apple is reportedly considering adding "live" sessions to its Fitness+ subscription service, indicated by a recent job posting for a studio producer focusing on live or live-to-tape multi-camera production. While the exact nature of these sessions is unclear, they could involve either truly live …

Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Aquestive Therapeutics, Inc. (AQST) for alleged corporate wrongdoing. The firm is encouraging stockholders who purchased Aquestive securities before June 16, 2025, and still hold them, to contact them to assist with the investigation. The …

Aquestive (NASDAQ: AQST) CCO's 2,714-share tax withholding detailed

Aquestive Therapeutics' Chief Commercial Officer, Sherry Korczynski, had 2,714 shares of company common stock withheld to cover tax obligations stemming from the vesting of Restricted Stock Units. The shares were valued at $4.25 each. Following this transaction, Korczynski directly holds 235,689 shares of Aquestive …

AppLovin (APP) Offers Attractive Cash Flow Multiple?

Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the …

Applied Optoelectronics (AAOI) logs 46.7% four-week rebound in weekly context

The communication-equipment stock’s recovery is powerful, but the setup is still mixed as longer-term performance and Market Dynamics remain softer.

Greenlight Capital Re (GLRE) Q2 2026 Earnings Call

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS General Counsel - David Sigmon Chief Executive Officer - Greg Richardson Chairman of the Board - David Einhorn Chief Financial Officer - Faramarz Romer Full Conference Call Transcript …

Check-Cap files prospectus for $12.5 million ordinary share offering

Check-Cap has filed a prospectus with the US Securities and Exchange Commission (SEC) for an offering of ordinary shares valued at $12.5 million. This move aims to raise capital through equity issuance in the US market. The filing outlines the details of the proposed …

Traders Buy Large Volume of Apollo Global Management Put Options (NYSE:APO)

Fulcrum Therapeutics Target of Unusually Large Options Trading (NASDAQ:FULC)

Marcus & Millichap Brokers $7.2M Sale of Multifamily Asset in Miami

Marcus & Millichap announced the $7.2 million sale of Sun King Apartments in Miami to a local investor. The 39-unit multifamily property, built in 1966, was sold in an off-market transaction by Marcus & Millichap’s Fort Lauderdale office, with Felipe Echarte, Evan Kristol, and …

8-K: APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. REPORTS FIRST QUARTER 2026 RESULTS - moomoo

This article announces that Apollo Commercial Real Estate Finance, Inc. has reported its first-quarter 2026 financial results. The full details are available in the linked 8-K document.

Ocular gains on EyePoint phase 3 wet AMD miss

[AMD Abbreviation or acronym of age-related macular degeneration - eye problem in older persons. Word AMD is on foreground near eye model with stethoscope and visual acuity test on blurry background] Shidlovski * Ocular Therapeutix (OCUL [https://seekingalpha.com/symbol/OCUL]) is up ~7% Monday following rival EyePoint's …

GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control

Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the …

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

Contineum Therapeutics (CTNM), Disc Medicine (IRON), and Recursion Pharmaceuticals (RXRX) are making PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign …

Emperor Capital Group to Sell Target Company Stake for HK$37 Million

WRAP Looks 12.0% Undervalued on GF Value™ Despite Unprofitable Status

Wrap Technologies Inc. (NASDAQ: WRAP) recently announced a direct offering of 8.57 million shares at $1.40 each, aiming to raise $12 million for corporate needs and expansion, which led to a 9.04% stock decline. Despite its unprofitable status with negative margins and revenue contraction, …

Summit Therapeutics (NASDAQ:SMMT) Hits New 1-Year Low - Here's Why

Summit Therapeutics (NASDAQ:SMMT) shares recently hit a new 52-week low, trading at approximately $12.20, below both their 50-day and 200-day moving averages. This drop follows lowered analyst price targets, a consensus "Hold" rating, and the company narrowly missing quarterly earnings estimates with a loss …

Saputo (TSX:SAP) Can Its Dividend Weather Profit Pressure?